What did @nataliemurray75 actually say?
Natalie filmed her testosterone pellet insertion appointment with Dr. Rockhead, capturing the procedure in real time. The most specific clinical claim came from her provider: "based on your weight, we're going to give you 150 grams of testosterone." She also relayed that the pellets "last about six months," with a caveat that her active lifestyle might shorten that window. She described the procedure as painless, finishing in under two minutes, and walked out with a bandage the size of a postage stamp.
The video is largely experiential rather than instructional, which limits some of the harm potential. Still, two specific claims, the dosing figure and the six-month duration, deserve scrutiny because they're the kind of numbers viewers screenshot and bring into their own doctor's appointments.
Does the science back this up?
The six-month duration claim is broadly supported for subcutaneous pellets, but the dosing figure has a serious problem. The transcript says "150 grams," which is not a real clinical dose. That figure is almost certainly a transcription or speech error for 150 milligrams, a number that sits within reported ranges for women. But the distinction matters.
Studies on testosterone pellet therapy in women, including Davis et al. (2019, Lancet Diabetes and Endocrinology), report typical female dosing in the range of 50-150 mg per insertion, with duration of effect between three and six months depending on metabolic rate and physical activity. The provider's note that Natalie's activity level might shorten duration is consistent with this literature. More active individuals have higher testosterone turnover, and pellet absorption does accelerate with physical exertion (Glaser and Dimitrakakis, 2013, Maturitas).
So the science roughly supports the duration claim and the activity caveat. It does not support a "150 grams" dose, because that would be lethal.
What did they get wrong (or right)?
The "150 grams" figure is wrong, full stop. Whether it was a slip of the tongue by the provider, a mishearing by Natalie, or a transcription error, broadcasting a dosing number that is off by a factor of 1,000 is not a minor mistake. Viewers who are already suspicious of medical authority will treat that number as gospel. Viewers who are research-oriented will be confused. Neither outcome is good.
What Natalie got right: she correctly captured that pellets are inserted subcutaneously in the upper outer gluteal region, that the procedure is genuinely fast (under two minutes is typical), and that discomfort is usually minimal with proper local anesthesia. The pain experience she described, essentially none, is consistent with patient-reported outcomes in Glaser et al. (2009, Maturitas), where the procedure was rated low-discomfort by the majority of participants.
The six-month claim also needs a small correction. Three to four months is more common for women. Six months is on the longer end of the published range and may set unrealistic expectations for some patients.
What should you actually know?
Testosterone pellet therapy in perimenopausal women is a real and increasingly studied intervention, but it sits in a regulatory gray zone. The FDA has not approved any testosterone product specifically for women in the United States, meaning pellets are compounded and not subject to the same manufacturing oversight as approved drugs. That does not make them dangerous by default, but it does mean quality and dosing consistency can vary by pharmacy.
The evidence base is growing. A 2021 systematic review by Islam et al. (Journal of the Endocrine Society) found improvements in sexual function and quality-of-life scores with testosterone therapy in women, but noted that long-term cardiovascular and breast cancer safety data remain limited. The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018) recommend against using male-range testosterone doses in women and emphasize monitoring for androgenic side effects like acne, hair loss, and voice changes.
If you are considering pellet therapy, ask your provider for the milligram dose in writing, ask which compounding pharmacy they use, and ask how they monitor your levels. "It lasts six months" is a starting point, not a guarantee.